RetinaLogik develops eye screening and virtual reality-based vision testing technology.
Founded in 2019 in Alberta, Canada, RetinaLogik develops medical equipment and software for ophthalmic diseases. Its AI supports glaucoma diagnosis, and its virtual reality-based visual field testing is designed to use existing technology infrastructure. In February 2025, the company raised CAD 1.1 million in venture debt funding from returning investors UCeed Haskayne Student Fund, Spring Impact Capital, Halo Health, Inc. and Startup TNT, along with new and individual investors. It plans to use the funding to expand in North America.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in